Jujube in metabolic syndrome
Phase 3
Recruiting
- Conditions
- Metabolic syndrome.Metabolic syndromeE88.81
- Registration Number
- IRCT20180201038585N10
- Lead Sponsor
- Bagheiat-allah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Military personnel with metabolic syndrome
Age 30-50 years
Willing to participate in the study
Exclusion Criteria
Follow special diets
Other diseases such as kidney, liver, thyroid and parathyroid, lung, cancer, and heart disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Mercury sphygmomanometer.;Weight. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Scale.;Body mass index. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Equation, Weight(kg)/[height(m)]2.;Lipid profile. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Through intravenous blood samples and commercial kits.;Fasting blood glucose. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Through intravenous blood samples and commercial kits.;Waist circumference. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Tape.
- Secondary Outcome Measures
Name Time Method Depression score. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: DASS-21 questionnaire.;Stress score. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: DASS-21 questionnaire.;Anxiety score. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: DASS-21 questionnaire.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie jujube's effects on lipid metabolism and insulin resistance in metabolic syndrome?
How does jujube supplementation compare to statins or metformin in improving anthropometric and glycemic parameters in metabolic syndrome patients?
Which biomarkers (e.g., adiponectin, CRP) correlate with jujube-induced improvements in blood pressure and lipid profiles in Phase III trials?
What adverse events are associated with jujube consumption in military populations, and how do they compare to standard metabolic syndrome therapies?
Are there synergistic effects of combining jujube with omega-3 fatty acids or berberine in managing metabolic syndrome subtypes (e.g., visceral obesity vs. dyslipidemia-dominant)?